Video
Ilo Leppik, MD
Publish date: April 27, 2016
At the 68th Annual Meeting of the American Academy of Neurology, Dr. Leppik discusses epilepsy in the elderly and an approach to selecting medications for this patient population.
Recommended Reading
Related Articles
Conference Coverage
-
Noninvasive testing in midlife flags late-onset epilepsy risk Publish date: April 27, 2023 -
Novel neural cell therapy: A cure for focal epilepsy? Publish date: April 24, 2023 -
Seizures in dementia hasten decline and death Publish date: December 14, 2022 -
Three antiseizure medications join list for newborn risks Publish date: December 13, 2022 -
‘Striking’ rate of mental health comorbidities in epilepsy Publish date: December 12, 2022 -
Significant racial disparities persist in status epilepticus Publish date: December 12, 2022 -
Study implicates myelin plasticity in absence seizures Publish date: December 9, 2022 -
Newer brand-name drugs fuel spending on antiseizure medications -
Diazepam nasal spray effective in Lennox-Gastaut syndrome Publish date: October 24, 2022 -
Antiseizure medication appears safe in pregnancy
Multimedia
-
Patients describe significant impact of epilepsy on their lives -
Tatiana Falcone, MD Publish date: December 18, 2017 -
Andrew G. Herzog, MD Publish date: December 18, 2017
Literature Review
-
Minorities with epilepsy blocked from receiving ‘highest quality of care’ -
Modified Atkins diet beneficial in drug-resistant epilepsy -
Antiepileptic drugs tied to increased Parkinson’s disease risk -
Strong two-way link between epilepsy and depression Publish date: December 6, 2022 -
High drug costs exclude most neurology patients from cutting-edge treatment -
Drug-resistant epilepsy needs earlier surgical referral -
‘Striking’ jump in cost of brand-name epilepsy meds -
Air pollution is a seizure trigger for patients with epilepsy -
New guidance on cannabis use for treatment-resistant epilepsy -
ILAE offers first guide to treating depression in epilepsy
Neurobehavioral comorbidities of epilepsy
Question 1 of 5